Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice

BACKGROUND: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) have been widely used for the treatment of non-small cell lung cancer (NSCLC). KRAS and EGFR somatic mutations in NSCLC may predict resistance and responsiveness to TKI, respectively. Nevertheless, most research to da...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Leina, Zhang, Qiang, Luan, Huanling, Zhan, Zhongli, Wang, Changli, Sun, Baocun
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069944/
https://www.ncbi.nlm.nih.gov/pubmed/21414214
http://dx.doi.org/10.1186/1756-9966-30-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069944/
https://www.ncbi.nlm.nih.gov/pubmed/21414214
http://dx.doi.org/10.1186/1756-9966-30-30

Ejemplares similares